Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|April 5, 2018
Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patientsTara M Robinson, Gabrielle T Prince, Chris Thoburn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemiaYvette L Kasamon, Ian W Flinn, Michael R Grever, et al.
The American Journal of Surgical Pathology|February 15, 2014
HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphomaGenevieve M Crane, Richard F Ambinder, Courtney M Shirley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2010
Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomasYvette L Kasamon, Richard J Jones, Christopher D Gocke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2018
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell LymphomaNajat Bouchkouj, Yvette L Kasamon, R Angelo de Claro, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvementYvette L Kasamon, Richard J Jones, Steven Piantadosi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 2013
Partially mismatched transplantation and human leukocyte antigen donor-specific antibodiesDouglas E Gladstone, Andrea A Zachary, Ephraim J Fuchs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2024
FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell LymphomasMaryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu, et al.
The Oncologist|August 18, 2018
FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic MastocytosisYvette L Kasamon, Chia-Wen Ko, Sriram Subramaniam, et al.
The Oncologist|June 16, 2021
FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell LymphomaYvette L Kasamon, Lauren S L Price, Olanrewaju O Okusanya, et al.
Pageof 6